BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 171424)

  • 1. Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls.
    Pacsa AS; Kummerländer L; Pejtsik B; Pali K
    J Natl Cancer Inst; 1975 Oct; 55(4):775-81. PubMed ID: 171424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
    McDonald AD; Williams MC; Manfreda J; West R
    Am J Epidemiol; 1974 Aug; 100(2):130-5. PubMed ID: 4368955
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls.
    Feorino PM; Palmer EL
    J Infect Dis; 1973 Jun; 127(6):732-5. PubMed ID: 4350521
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to herpesvirus hominis types 1 and 2 among women with neoplastic change of uterine cervix.
    Peltonen R
    Acta Obstet Gynecol Scand; 1975; 54(4):369-72. PubMed ID: 173131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of herpesvirus-induced antigens in human cervical cancer.
    Dreesman GR; Burek J; Adam E; Kaufman RH; Melnick JL; Powell KL; Purifoy DJ
    Nature; 1980 Feb; 283(5747):591-3. PubMed ID: 6243743
    [No Abstract]   [Full Text] [Related]  

  • 6. An analysis of seroepidemiological studies of herpesvirus type 2 and carcinoma of the cervix.
    Rawls WE; Adam E; Melnick JL
    Cancer Res; 1973 Jun; 33(6):1477-82. PubMed ID: 4352385
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to herpesviruses in patients with cervical cancer and controls.
    Muñoz N; de-Thé G; Aristizabal N; Yee C; Rabson A; Pearson G
    IARC Sci Publ (1971); 1975; (11 Pt 2):45-51. PubMed ID: 191382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective studies of the association of genital herpes simplex infection and cervical anaplasia.
    Nahmias AJ; Naib ZM; Josey WE; Franklin E; Jenkins R
    Cancer Res; 1973 Jun; 33(6):1491-7. PubMed ID: 4352387
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid detection of human cytomegalovirus and herpesvirus hominis IgM antibody by the immunoperoxidase technique.
    Gerna G; Chambers RW
    Intervirology; 1977; 8(5):257-71. PubMed ID: 195911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus-specific antigens in exfoliated cervical cells from women with and without cervical anaplasia.
    Pacsa AS; Kummerländer L; Pejtsik B; Krommer K; Pali K
    Cancer Res; 1976 Jul; 36(7 PT 1):2130-2. PubMed ID: 179696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to Herpesvirus hominis in patients with carcinoma of the cervix.
    Najem SN; Barton IG; Al-Omar LS; Potter CW
    Br J Exp Pathol; 1982 Oct; 63(5):485-9. PubMed ID: 6293526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls.
    Aurelian L; Cornish JD; Smith MF
    IARC Sci Publ (1971); 1975; (11 Pt 2):79-87. PubMed ID: 191387
    [No Abstract]   [Full Text] [Related]  

  • 13. Humoral-and cell-mediated immune responses to herpesvirus antigens in patients with cervical carcinoma.
    Kumar A; Selim MS; Madden DL; Wallen WC; Vasquez HH; Nankervis GA
    Gynecol Oncol; 1980 Aug; 10(1):18-25. PubMed ID: 6249698
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum antibodies to herpesvirus early antigens in patients with cervical carcinoma determined by anticomplement immunofluorescence technique.
    Ito H; Tsutsui F; Kurihara S; Akabayashi T; Tobe T
    Int J Cancer; 1976 Nov; 18(5):557-63. PubMed ID: 62718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to herpesvirus type 1 and type 2 among Japanese cervical cancer patients.
    Ozaki Y; Ishiguro T; Ohashi M; Sawaragi I; Ito Y
    Gan; 1978 Feb; 69(1):119-22. PubMed ID: 640320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital Chlamydia trachomatis infections in patients with cervical atypia.
    Paavonen J; Vesterinen E; Meyer B; Saikku P; Suni J; Purola E; Saksela E
    Obstet Gynecol; 1979 Sep; 54(3):289-91. PubMed ID: 224353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlations between herpesvirus and cervix carcinoma based on antigen-antibody studies].
    Sándor P; Lajos K; Béla P; Kálmán P
    Orv Hetil; 1975 Nov; 116(46):2711-5. PubMed ID: 172829
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
    Ito H; Kurihara S; Nishimura C
    Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
    [No Abstract]   [Full Text] [Related]  

  • 19. Chlamydia trachomatis and herpes simplex virus IgA antibodies in cervical secretions of patients with cervical atypia.
    Kalimo K; Terho P; Honkonen E; Grönroos M; Halonen P
    Br J Obstet Gynaecol; 1981 Nov; 88(11):1130-4. PubMed ID: 6271164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of Cytomegalovirus, Epstein-Barr virus and Herpesvirus hominis (types 1 and 2) antibody in institutionalized and non-institutionalized children.
    McMillan BC; Golubjatnikov R; Hanson RP; Sinha SK
    Health Lab Sci; 1977 Oct; 14(4):261-8. PubMed ID: 199558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.